(STEP) Stepstone - Ratings and Ratios
Private Equity, Venture Capital, Fund-Of-Funds, Secondary Investments, Real Assets
STEP EPS (Earnings per Share)
STEP Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 34.6% |
| Value at Risk 5%th | 54.0% |
| Relative Tail Risk | -5.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.15 |
| Alpha | -25.54 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.269 |
| Beta | 1.673 |
| Beta Downside | 1.953 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.27% |
| Mean DD | 10.00% |
| Median DD | 7.63% |
Description: STEP Stepstone November 05, 2025
StepStone Group Inc. (NASDAQ: STEP) is a global private-equity and venture-capital platform that deploys capital across primary and secondary strategies, including direct investments, fund-of-funds, co-investments and follow-on commitments.
Its direct-investment mandate spans the full capital-structure spectrum-from private-debt and venture-debt to mezzanine, distressed, growth-capital and buyout deals-targeting sectors such as technology, healthcare, clean energy, infrastructure, consumer durables and real assets.
Geographically, StepStone operates in North America, Europe, Asia and Latin America, allocating roughly 5-40 % of its capital to emerging-market opportunities, with notable exposure in Brazil, India and South-Korea.
As of the most recent filing, the firm reported approximately $71 billion in assets under management (AUM) and generated $1.12 billion of revenue in FY 2023, reflecting a 12 % YoY increase driven by strong fundraising activity in the private-equity sector.
Industry-wide, private-equity fundraising grew about 10 % in 2023, while capital deployment in emerging markets accelerated 15 % YoY, underscoring the relevance of StepStone’s diversified, global approach.
For a deeper quantitative view of STEP’s valuation metrics and peer comparison, you may find ValueRay’s analyst toolkit useful.
STEP Stock Overview
| Market Cap in USD | 7,715m |
| Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 2020-09-16 |
| Return 12m vs S&P 500 | -16.3% |
| Analyst Rating | 3.83 of 5 |
STEP Dividends
| Dividend Yield | 2.22% |
| Yield on Cost 5y | 5.46% |
| Yield CAGR 5y | 42.88% |
| Payout Consistency | 98.6% |
| Payout Ratio | 69.9% |
STEP Growth Ratios
| CAGR 3y | 32.85% |
| CAGR/Max DD Calmar Ratio | 0.86 |
| CAGR/Mean DD Pain Ratio | 3.29 |
| Current Volume | 835.9k |
| Average Volume | 536.7k |
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-615.1m TTM) > 0 and > 6% of Revenue (6% = 92.1m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -2.86pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -102.0% (prev 22.81%; Δ -124.8pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 23.6m > Net Income -615.1m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.17 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (78.6m) change vs 12m ago 12.72% (target <= -2.0% for YES) |
| Gross Margin 6.52% (prev 46.65%; Δ -40.13pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 32.76% (prev 19.81%; Δ 12.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -69.89 (EBITDA TTM -1.01b / Interest Expense TTM 15.2m) >= 6 (WARN >= 3) |
Altman Z'' -4.07
| (A) -0.29 = (Total Current Assets 311.3m - Total Current Liabilities 1.88b) / Total Assets 5.33b |
| (B) -0.14 = Retained Earnings (Balance) -720.4m / Total Assets 5.33b |
| (C) -0.23 = EBIT TTM -1.06b / Avg Total Assets 4.69b |
| (D) -0.18 = Book Value of Equity -719.4m / Total Liabilities 4.11b |
| Total Rating: -4.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.96
| 1. Piotroski 1.0pt = -4.0 |
| 2. FCF Yield 0.24% = 0.12 |
| 3. FCF Margin 1.23% = 0.31 |
| 4. Debt/Equity -1.64 = -2.50 |
| 5. Debt/Ebitda 0.23 = 2.46 |
| 7. RoE -794.5% = -2.50 |
| 8. Rev. Trend 50.31% = 3.77 |
| 9. EPS Trend 85.95% = 4.30 |
What is the price of STEP shares?
Over the past week, the price has changed by -2.33%, over one month by -1.46%, over three months by +2.30% and over the past year by -4.06%.
Is Stepstone a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of STEP is around 64.65 USD . This means that STEP is currently overvalued and has a potential downside of 2.47%.
Is STEP a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the STEP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74.9 | 18.7% |
| Analysts Target Price | 74.9 | 18.7% |
| ValueRay Target Price | 74.1 | 17.5% |
STEP Fundamental Data Overview November 16, 2025
P/E Forward = 30.9598
P/S = 5.0253
P/B = 33.0017
Beta = 1.434
Revenue TTM = 1.54b USD
EBIT TTM = -1.06b USD
EBITDA TTM = -1.01b USD
Long Term Debt = 269.9m USD (from longTermDebt, last quarter)
Short Term Debt = 269.3m USD (from shortTermDebt, last fiscal year)
Debt = 382.8m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -229.8m USD (from netDebt column, last quarter)
Enterprise Value = 7.87b USD (7.72b + Debt 382.8m - CCE 229.8m)
Interest Coverage Ratio = -69.89 (Ebit TTM -1.06b / Interest Expense TTM 15.2m)
FCF Yield = 0.24% (FCF TTM 18.9m / Enterprise Value 7.87b)
FCF Margin = 1.23% (FCF TTM 18.9m / Revenue TTM 1.54b)
Net Margin = -40.06% (Net Income TTM -615.1m / Revenue TTM 1.54b)
Gross Margin = 6.52% ((Revenue TTM 1.54b - Cost of Revenue TTM 1.44b) / Revenue TTM)
Gross Margin QoQ = 45.57% (prev 47.38%)
Tobins Q-Ratio = 1.48 (Enterprise Value 7.87b / Total Assets 5.33b)
Interest Expense / Debt = 1.16% (Interest Expense 4.42m / Debt 382.8m)
Taxrate = -14.85% (negative due to tax credits) (100.3m / -675.8m)
NOPAT = -1.22b (EBIT -1.06b * (1 - -14.85%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 0.17 (Total Current Assets 311.3m / Total Current Liabilities 1.88b)
Debt / Equity = -1.64 (negative equity) (Debt 382.8m / totalStockholderEquity, last quarter -233.5m)
Debt / EBITDA = 0.23 (negative EBITDA) (Net Debt -229.8m / EBITDA -1.01b)
Debt / FCF = -12.14 (Net Debt -229.8m / FCF TTM 18.9m)
Total Stockholder Equity = 77.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -11.54% (Net Income -615.1m / Total Assets 5.33b)
RoE = -794.5% (Net Income TTM -615.1m / Total Stockholder Equity 77.4m)
RoCE = -305.0% (out of range, set to none) (EBIT -1.06b / Capital Employed (Equity 77.4m + L.T.Debt 269.9m))
RoIC = -378.0% (out of range, set to none) (NOPAT -1.22b / Invested Capital 321.8m)
WACC = 11.67% (E(7.72b)/V(8.10b) * Re(12.18%) + D(382.8m)/V(8.10b) * Rd(1.16%) * (1-Tc(-0.15)))
Discount Rate = 12.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.01%
[DCF Debug] Terminal Value 58.48% ; FCFE base≈63.3m ; Y1≈48.4m ; Y5≈30.1m
Fair Price DCF = 4.11 (DCF Value 325.2m / Shares Outstanding 79.1m; 5y FCF grow -27.87% → 3.0% )
EPS Correlation: 85.95 | EPS CAGR: 28.67% | SUE: 0.73 | # QB: 0
Revenue Correlation: 50.31 | Revenue CAGR: 165.6% | SUE: 1.47 | # QB: 3
Additional Sources for STEP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle